ProBiotix Health plc

Company Profile

Company website
Pharmaceuticals and Biotechnology (Biotechnology)

Description: ProBiotix Health (AQSE: PBX) is a spin-out of OptiBiotix Health Plc. The Company was established in 2018, with the purpose to provide consumers and industry world-wide with uncompromised supply and service of safe and scientifically validated probiotic-based microbiome product solutions for improvement of human health.

ProBiotix Health hold a unique position within fast growing cardiovascular health segment and has become a global leader for development and marketing of finished dietary supplement and OTC probiotic based microbiome solution aiming at lowering of cholesterol and blood pressure using its principal strain, LPLDL®.

Investor Access

28 Jun
Event information
The company will release to the Full Year Results (the period ended 31 December 2022) on Wednesday, 28 June 2023
Wednesday, 28 June 2023
Financial Calendar
 Event Date
Year End31 December
Half  Year End30 June
Preliminary Results*June
Interim Results*September

* Months based on previous announcements of this kind